This study was carried out within the context of discussions concerning future strategies for the control and prevention of polio. Intermediate revenue countries may be confronted with the decision either to stop polio vaccination and to strengthen surveillance of cases of acute flaccid paralysis (AFP), or to provide inactivated polio vaccine (IPV) to the population without strengthening surveillance. An economic comparison of these two strategies will necessitate an estimation of the costs of the different components of surveillance.